• Explore /
  • Poster
  • / A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer.

A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer.

Abstract Poster

Authors

null

Amr Hesham Abdelhamid Ahmed

Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA

Amr Hesham Abdelhamid Ahmed , Marika D. Russell , Natalia Kyriazidis , Amanda Silver Karcioglu , Eric Jeffrey Sherman , Alan Loh Ho , James A Fagin , Richard J. Wong , Naifa Lamki Busaidy , Mark E. Zafereo , Peter Sadow , Jong Chul Park , Lori J. Wirth , Gregory W. Randolph

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT04321954

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS6105)

DOI

10.1200/JCO.2023.41.16_suppl.TPS6105

Abstract #

TPS6105

Poster Bd #

95a

Abstract Disclosures

Similar Posters

First Author: Shun Zhang

First Author: Yongkang Xu

First Author: Bryan Haugen

First Author: Anthony Paul Gulati